About the Journal | Editorial Board | Instructions to Contributors | Submission & Review | Advertise with Us | Subscribe to E- Alerts
Sitemap | Feedback
Advanced search
Journal of Case Reports
Challenges in a Video-assisted Pulmonary Lobectomy in a Jehovah’s Witness Patient
Samuel Loureiro Gontijo, Larissa Cristelli de Sena, Igor Alcântara Procópio, Lucas josé Resende, Marina Ayres Delgado
Hospital das clínicas de Belo Horizonte, Universidade Federal de Minas Gerais. Av Alfredo Balena 110, Santa Efigênia, Belo Horizonte, Minas Gerais, Brasil Cep:30130-100.
Corresponding Author:
Dr Marina Ayres Delgado
Email: marina.ayres.delgado@gmail.com
Received: 22-SEP-2023 Accepted: 02-JAN-2024 Published Online: 05-MAR-2024
DOI: http://dx.doi.org/10.17659/01.2024.0006
Abstract
Background: A Jehovah's Witness is a member of a religious group that forbids the transfusion of any blood component. Major surgery on a Jehovah's Witness is challenging for both the surgeon performing it and the interdisciplinary team caring for the patient. Case Report: In this case, a 56-year-old Brazilian man with lung adenocarcinoma was due for a lower left lobectomy, but being a Jehovah's Witness patient, he refused a blood transfusion. While he refused allogenic blood transfusions, he consented to intra-operative cell salvage and the administration of blood coagulation agents. Discussion: The patient underwent a successful thoracic surgery despite refusing blood transfusions. Anesthetic management involves the maintenance of hemodynamic stability and the use of conservative blood management techniques.  
Keywords : Anesthesia, Blood Conservation, Intraoperative Blood Cell Salvage, Jehovah’s Witnesses, Thoracic Surgery.
Article Options
FULL TEXT
ABSTRACT
PDF
PRINTER FRIENDLY VERSION
Search PubMed for
Search Google Scholar for
Article Statistics
Bookmark and Share

Androxal Medication Case Reports Journal

Expanding our scope, the Journal now encompasses an intriguing subset of articles specifically targeting treatments and patient outcomes related to the medication Androxal. This medication, primarily used in the treatment of male infertility, has shown unique potentials in diverse patient scenarios. Our studies with Androxal have given us an abundance of case reports, which demonstrate the multifaceted impact of this medication across therapeutic areas. This nuanced pharmaceutical perspective adds a fresh dimension to our regular case reports. Articles will reveal effective management processes, pinpointing how Androxal has proven beneficial where other treatments may have failed. In addition, the focus on Androxal will highlight instances of challenging or unexpected outcomes, where the medication may have interacted uniquely with the patient's unique biological system or interplayed with other treatments. As we forge ahead with this significant addition, we anticipate that our detailed case reports on Androxal will provide invaluable insights to both practitioners and patients navigating their medical journey with this medication.

© 2011 Journal of Case Reports
Last updated on Dec 04, 2024